(HealthDay News) – For pediatric patients undergoing hemopoietic stem-cell transplantation (HSCT), defibrotide prophylaxis may reduce the incidence of hepatic veno-occlusive disease, according to the ...
Please provide your email address to receive an email when new articles are posted on . SALT LAKE CITY — Defibrotide benefitted adults and pediatric patients with severe or very severe veno-occlusive ...
DUBLIN, April 29, 2020 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that enrollment in the Phase 3 clinical study of defibrotide for the prevention of hepatic veno-occlusive ...
VILLA GUARDIA (COMO), Italy--(BUSINESS WIRE)--Gentium S.p.A. (NASDAQ: GENT) today announced top-line results from a historically controlled, multicenter, open label, Phase III trial designed to ...
Measuring mercaptopurine (6MP) adherence using red cell 6MP metabolite levels in children with acute lymphoblastic leukemia (ALL): A COG AALL03N1 study. This is an ASCO Meeting Abstract from the 2017 ...
The European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) yesterday issued a negative opinion on Gentium SpA's marketing application for defibrotide (Defitelio) for ...
Normal penile erection requires compression of subtunical veins against the tunica albuginea. The role of the intracorporal septum in veno-occlusion has not been described. We report a case of ...
Better survival with fludarabine and timed sequential busulfan regimen in older patients with AML/MDS. This is an ASCO Meeting Abstract from the 2017 ASCO Annual Meeting I. This abstract does not ...
M. Patricia George, Enrico M. Novelli, Norihisa Shigemura, Marc A. Simon, Brian Feingold, Lakshmanan Krishnamurti, Matthew R. Morrell, Cynthia G. Gries, Syed Haider ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback